Staff editor

Morten Isaksen (Bio-Me): ‘The Importance of Standardisation in Microbiome Analysis’

Biopharma companies are currently developing Live Biotherapeutic Products. We discussed this topic with Morten Isaksen (BIO-ME).

Beiersdorf acquires S-Biomedic and strengthens expertise in the field of acne treatment

Strategic investment in dynamic research field of skin microbiome to drive future of skin care.

Personalized human gut microbiome responses to dietary intervention through a multiomic perspective

Emily Hollister discussed how Diversigen demonstrates the rapidity of microbial gene expression changes potentially impacting host-microbiome interactions.

MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program

With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases.

Novozymes and Chr. Hansen to merge and create a leading global biosolutions partner

The new group will have annual revenues of approximately 3.5 billion euros ($3.7 billion), the companies said.

Federation Bio Administers First Dose in Phase 1 Clinical Trial Evaluating Investigational Bacterial Cell Therapy

FB-001 is a rationally designed consortium of 148 defined bacterial strains with unprecedented diversity, representing a complete microbiome replacement

Benjamin Hadida – Translating the potential of . Faecalibacterium prausnitzii In Crohn’s Disease to the clinical Sstage

Benjamin Hadida discusses how to validate innovative clinical trial design and overcome challenges of robust-large scale manufacturing.

FDA Approves First Fecal Microbiota Product

Rebyota Approved for the Prevention of Recurrence of Clostridioides difficile Infection in Adults

Nestlé microbiome breakthrough discovery in infant gut microbiome

The discovery contributes to the understanding of the infant gut microbiome and how it evolves during development.

Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership

This strategic partnership is set to accelerate the international distribution of Microba’s microbiome testing into primary and specialist healthcare, and move our testing deeper into routine patient management.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top